FI954499A0 - Menetelmä ja analyysi - Google Patents

Menetelmä ja analyysi

Info

Publication number
FI954499A0
FI954499A0 FI954499A FI954499A FI954499A0 FI 954499 A0 FI954499 A0 FI 954499A0 FI 954499 A FI954499 A FI 954499A FI 954499 A FI954499 A FI 954499A FI 954499 A0 FI954499 A0 FI 954499A0
Authority
FI
Finland
Prior art keywords
pct
sec
date
human
subject
Prior art date
Application number
FI954499A
Other languages
English (en)
Swedish (sv)
Other versions
FI954499A (fi
FI113206B (fi
Inventor
Nils Olav Solum
Frank Brosstad
Paol Andre Holme
Geir Olav Gogstad
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI954499(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of FI954499A publication Critical patent/FI954499A/fi
Publication of FI954499A0 publication Critical patent/FI954499A0/fi
Application granted granted Critical
Publication of FI113206B publication Critical patent/FI113206B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicinal Preparation (AREA)
  • Holo Graphy (AREA)
  • Telephone Function (AREA)
FI954499A 1993-03-24 1995-09-22 Tiettyjen hemostaattisten häiriöiden diagnoosimenetelmä ja testipakkaus FI113206B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9306053 1993-03-24
GB939306053A GB9306053D0 (en) 1993-03-24 1993-03-24 Method and assay
PCT/GB1994/000592 WO1994022018A1 (en) 1993-03-24 1994-03-23 Method and assay
GB9400592 1994-03-23

Publications (3)

Publication Number Publication Date
FI954499A FI954499A (fi) 1995-09-22
FI954499A0 true FI954499A0 (fi) 1995-09-22
FI113206B FI113206B (fi) 2004-03-15

Family

ID=10732620

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954499A FI113206B (fi) 1993-03-24 1995-09-22 Tiettyjen hemostaattisten häiriöiden diagnoosimenetelmä ja testipakkaus

Country Status (13)

Country Link
US (1) US5811250A (fi)
EP (1) EP0694168B2 (fi)
JP (1) JP3422491B2 (fi)
AT (1) ATE154847T1 (fi)
AU (1) AU691489B2 (fi)
CA (1) CA2158363C (fi)
DE (1) DE69403961T3 (fi)
DK (1) DK0694168T4 (fi)
ES (1) ES2103582T5 (fi)
FI (1) FI113206B (fi)
GB (1) GB9306053D0 (fi)
NO (1) NO953770L (fi)
WO (1) WO1994022018A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
NO20031431D0 (no) * 2003-03-28 2003-03-28 Forskningsparken As Metode for å diagnostisere hemostatiske forstyrrelser ved bruk av mikrovesikler fra blodplater
ES2571929T3 (es) * 2004-05-26 2016-05-27 Region Nordjylland Procedimiento para determinar la cantidad de CD36 circulante
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
WO2006088976A2 (en) * 2005-02-16 2006-08-24 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
US20100105088A1 (en) * 2007-02-05 2010-04-29 Aarhus Universitet method for diagnosing atherosclerotic plaques by measurement of cd36
US20090104649A1 (en) 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
ES2703363T3 (es) * 2008-02-01 2019-03-08 Massachusetts Gen Hospital Uso de microvesículas en el diagnóstico y pronóstico de tumores cerebrales
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
IT1398680B1 (it) * 2009-06-12 2013-03-08 Bios Internat S R L Metodo in vitro per la determinazione della proteina gp91phox come marker di stress ossidativo
WO2011031892A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2011031877A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
WO2011063324A2 (en) * 2009-11-20 2011-05-26 The General Hospital Corporation Microfluidic systems for isolating microvesicles
JP5753541B2 (ja) 2009-12-21 2015-07-22 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 抗ｖｅｇｆ治療によって治療された患者におけるタンパク尿の初期マーカー
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
JP6219721B2 (ja) 2010-11-10 2017-10-25 エキソソーム ダイアグノスティックス インコーポレイテッド 核酸含有粒子の単離および該粒子からの核酸の抽出のための方法
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities

Also Published As

Publication number Publication date
AU691489B2 (en) 1998-05-21
CA2158363A1 (en) 1994-09-29
EP0694168B2 (en) 2002-06-12
DK0694168T3 (da) 1997-07-21
EP0694168B1 (en) 1997-06-25
JP3422491B2 (ja) 2003-06-30
NO953770D0 (no) 1995-09-22
GB9306053D0 (en) 1993-05-12
AU6262794A (en) 1994-10-11
DE69403961T3 (de) 2003-01-16
FI954499A (fi) 1995-09-22
DE69403961D1 (de) 1997-07-31
CA2158363C (en) 2004-08-17
EP0694168A1 (en) 1996-01-31
ATE154847T1 (de) 1997-07-15
DK0694168T4 (da) 2002-09-30
DE69403961T2 (de) 1998-01-02
NO953770L (no) 1995-09-22
ES2103582T5 (es) 2002-12-16
FI113206B (fi) 2004-03-15
JPH08509806A (ja) 1996-10-15
ES2103582T3 (es) 1997-09-16
US5811250A (en) 1998-09-22
WO1994022018A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
FI954499A0 (fi) Menetelmä ja analyysi
JPS5726119B2 (fi)
NO923821D0 (no) Diagnostiske midler
GB9320850D0 (en) Monitoring the concentration of a substance or a group of substances in a body fluid of a human or an animal
DE69328550D1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
BR9611909A (pt) Sistema de tratamento de água de ponto de utilização
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
NO950594D0 (no) Fremgangsmåte for diagnostisering og overvåking av sepsis
DE59705193D1 (de) Ventil für flüssigkeiten
HK1014207A1 (en) Method for quantifying extracellular bpi in body fluids
DK0791073T3 (da) Analysemetode
PT870036E (pt) Α-n-acetilglucosaminidase de mamífero sintética e sequências genéticas codificando a mesma
DE69302276D1 (de) Diagnostische Methode
DE69319127D1 (de) Konjugat für den Nachweis und/oder Quantifizierung von biologischen Komponenten
Jacobs et al. Treatment-outcome interactions
Finlay Facing up to acne
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
DE69423796T2 (de) Testverfahren und Reagenz für Magnesium in menschlichen Körperflüssigkeiten
UA28749A (uk) Спосіб оцінки ефективності лікування гіпертонічної хвороби
RU97122225A (ru) Способ регуляции тканевых биологических барьеров, иммунитета и гомеостаза

Legal Events

Date Code Title Description
MA Patent expired